Policy
This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the Defense Health Agency’s (DHA’s) procedures to assign responsibilities and establish procedures for managing Clinical Quality Management (CQM) in the Military Health System (MHS). This DHA-PM replaces, in full, the contents of the DoD Manual 6025.13 (Reference (e)), which is targeted for cancellation.
Policy
This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the Defense Health Agency’s (DHA’s) procedures to assign responsibilities and establish procedures for managing Clinical Quality Management (CQM) in the Military Health System (MHS). This DHA-PM replaces, in full, the contents of the DoD Manual 6025.13 (Reference (e)), which is targeted for cancellation.
Policy
This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the Defense Health Agency’s (DHA’s) procedures to assign responsibilities and establish procedures for managing Clinical Quality Management (CQM) in the Military Health System (MHS). This DHA-PM replaces, in full, the contents of the DoD Manual 6025.13 (Reference (e)), which is targeted for cancellation.
Policy
This Defense Health Agency-Procedures Manual (DHA-PM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the Defense Health Agency’s (DHA’s) procedures to assign responsibilities and establish procedures for managing Clinical Quality Management (CQM) in the Military Health System (MHS). This DHA-PM replaces, in full, the contents of the DoD Manual 6025.13 (Reference (e)), which is targeted for cancellation.
Policy
This Defense Health Agency Interim Procedures Memorandum (DHA-IPM) describes the mission and objectives of the Nurse Advice Line Program and provides guidance and direction on the expected roles and responsibilities at all levels of the Military Health System (MHS). Please disseminate this message to all Medical Treatment Facility (MTF) commanders. This is effective immediately; it must be incorporated into Military Service Department NAL policies and a future Defense Health Agency-Procedural Instruction for MTFs. This DHA-IPM will expire October 31, 2019.
- Identification #: DHA-IPM 17-009
- Date: 8/30/2019
- Type: DHA Interim Procedures Memorandum
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), implementing instructions, assigns responsibilities, and prescribes procedures for the seasonal influenza vaccination program.
• This DHA-IPM cancels and reissues DHA-IPM 18-005.
• This DHA-IPM is effective immediately and will expire 12 months from the date of issue.
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (t), establishes the Defense Health Agency’s (DHA) procedures for MM program requirements to support standard and integrated care management implementation within the MHS.
- Identification #: DHA PI 6025.20
- Date: 8/27/2019
- Type: DHA Procedural Instruction
- Topics:
N/A
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (m), establishes the Defense Health Agency’s (DHA) procedures to develop a universally accepted, standardized Joint Trauma Lexicon. Change 1 Effective August 29, 2019.
- Identification #: DHA PI 6040.03 Change 1
- Date: 8/21/2019
- Type: DHA Procedural Instruction
- Topics:
N/A
Policy
This Air Force Policy Memorandum immediately establishes specific Air Force policy and provides guidance associated with the accession and in-service transition of exempt Airmen identifying as transgender with a diagnosis of gender dysphoria. Compliance with this memorandum is mandatory.
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity.
b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable.
c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a).
d. Supports the following objectives of the R&D EA:
(1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight.
(2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives.
(3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions.
(4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (j), establishes the Defense Health Agency’s (DHA) procedures to:
a. Oversee, manage, and administer population health management functions performed in alignment with military medical treatment facilities (MTFs).
b. Identify and implement strategies that support and improve population health and health outcomes for MHS beneficiaries.
- Identification #: DHA-PI 6025.19
- Date: 8/9/2019
- Type: DHA Procedural Instruction
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (e): - Establishes the Defense Health Agency’s (DHA) procedures for exercising Health Information Technology (IT) administration and management responsibilities for the Deputy Assistant Director Information Operations/J-6 (DAD IO/J-6) functions in the Military Health System (MHS). - Is binding on DoD Components and supports the Director’s, DHA, responsibility to develop appropriate administration and management models to maximize efficiencies in the activities carried out by the DHA and outlines high-level roles and responsibilities. - Is effective immediately; it will be converted into a future DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.
- Identification #: 18-006
- Date: 8/7/2019
- Type: DHA Interim Procedures Memorandum
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (e):
- Establishes the Defense Health Agency’s (DHA) procedures for implementing and managing high quality information technology (IT) services by the Chief Information Officer (CIO), Deputy Assistant Director Information Operations (DAD IO/J-6), Military Health System (MHS). The DHA Service Delivery Management program provides customers requesting IT services from the DAD IO/J-6 or Defense Information Systems Agency service catalogs with an on-demand, automated system that provides a single-entry point to submit service requests. The automated system enables DAD IO/J-6 to align business needs and use repeatable and scalable processes to holistically track, manage, and report on customer submitted requests for IT services from submission to fulfillment.
- Is binding on DoD Components and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by the DHA.
- This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction (DHA-PI). This DHA-IPM will expire effective 12 months from the date of issue.
- Identification #: 18-007
- Date: 8/7/2019
- Type: DHA Interim Procedures Memorandum
- Topics:
Technology
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (i), establishes the Defense Health Agency’s (DHA) procedures for identifying when, where, and what type of emergency power and/or standby generators are acceptable and appropriate for use within the Military Healthy System, including medical treatment facilities (MTFs), medical research facilities, and research laboratories. This DHA-IPM is effectively immediately; it will be incorporated into a DHA-Procedural Instruction and will expire effective 12 months from the date of issue or when the DHA-Procedural Instruction is signed, whichever comes first.
- Identification #: DHA-IPM 18-004
- Date: 7/26/2019
- Type: DHA Interim Procedures Memorandum
- Topics:
N/A
Policy
Establishes policy, assigns responsibilities, and provides procedures to establish a uniform DoD immunization program, in accordance with the authority in DoDD 6200.04 and DoD Instruction (DoDI) 1010.10.
Showing results 61 - 75
Page 5 of 76